FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
08/11/2021 21:47
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
- AU$37.28m
- AU$23.71m
- AU$6.84m
Australia Stock Exchange release from PHARMAXIS LTD PXS.AX : FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study